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Home-based Reach-to-Grasp training for people after stroke is feasible: a pilot 
randomised controlled trial 
  
Running title – Feasibility of Reach-to-Grasp training after stroke 
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Abstract  
Objective: To determine feasibility of a randomised controlled trial (RCT) of home-
based Reach-to-Grasp training after stroke.  
Design: single-blind parallel group RCT.  
Participants: Residual arm deficit less than 12 months post-stroke. 
Interventions: Reach-to-Grasp training in 14 one-hour therapist’s visits over 6 
weeks, plus one hour self-practice per day (total 56 hours). Control: Usual care. 
Main Measures: Action Research Arm Test (ARAT), Wolf Motor Function Test 
(WMFT), pre-randomisation, 7, 12, 24 weeks post-randomisation. 
Results: 47 participants (Reach-to-Grasp=24, usual care=23) were randomised over 
17 months;. Reach-to-Grasp participants received a median (IQR) 14 (13,14) visits, 
and performed 157 (96,211) repetitions per visit; plus 30 minutes (22,45) self-
practice per day. Usual care participants received 10.5 (5,14) therapist visits, 
comprising 38.6 (30,45) minutes of arm therapy with 16 (6,24) repetitions of 
functional tasks per visit.. The study was stopped before 11 patients reached the 24 
weeks assessment.   Median ARAT scores in the reach-to-grasp group were 8.5 
(3.0,24.0) at baseline and 14.5 (3.5,26.0) at 24 weeks compared to median of 4 at 
both time points (IQR: baseline (3.0,14.0), 24 weeks (3.0,30.0)) in the usual-care 
group. Median WMFT tasks completed at baseline and 24 weeks were 6 (3.0,11.5) 
and 8.5 (4.5,13.5) respectively in the reach-to-grasp group and 4 (3.0,10.0), 6 
(3.0,14.0) in the usual care group. Incidence of arm pain was similar between 
groups. 
Conclusions: An RCT of home-based Reach-to-Grasp training after stroke is 
feasible and safe. With ARAT being our preferred measure it is estimated that 240 
participants will be needed for a future two armed trial. 
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Introduction 
Each year 15 million people world-wide have a stroke1 and three quarters of 
them experience upper limb weakness, making everyday tasks like using a knife and 
fork, unscrewing the top off a jar or doing up buttons difficult or impossible 2. Current 
therapeutic practice leaves the majority of patients with limited capacity to use their 
affected arm even by six months after stroke 3  
A Cochrane overview of systematic reviews concluded that, no high quality 
GRADE evidence can be found for any routine clinical interventions to improve arm 
function after stroke, but that intensive repetitive task practice with a dose of 20 extra 
hours or more is emerging as a promising contender 9. National stroke guidelines 
advocate that people with difficulty using their affected arms should be given the 
opportunity to practise upper limb activities 10,11,12, yet adoption into practice is 
constrained by limited, ambiguous evidence 9.  Sufficiently powered, high-quality 
RCTs are required to strengthen the evidence and provide leverage for 
implementation into clinical practice 9. 
Home based task-specific upper limb training specifically focusing on Reach-
to-Grasp movements is particularly relevant, as reaching and grasping is essential 
for everyday functions such as retrieving objects, e.g. clothes, food and drink, and 
are used more frequently than other upper limb movements 13. 
To address the gap in clinical practice and research, a home based task-
specific Reach-to-Grasp training intervention for people with stroke has been 
developed that is acceptable to participants 14. This study was designed to establish 
the feasibility and safety of a future definitive RCT of home-based Reach-to-Grasp 
training after stroke and to provide pilot outcome data.  
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Objectives were to: 
1. Estimate recruitment rates and retention of participants. 
2. Measure outcomes for both groups to obtain information to determine the 
sample size for a definitive trial and to estimate the completeness of outcome 
data. 
3. Determine the dose and content of upper limb treatment delivered to both 
intervention (Reach-to-Grasp) and control (usual care) groups. 
4. Decide on the most appropriate primary outcome measure, the Action 
Research Arm Test (ARAT) or the Wolf Motor Function Test (WMFT), for use 
in a definitive trial. 
5. Capture adverse events in both groups 
6. Collect data on health and social care resource use to inform data-collection 
methods for an economic evaluation in the subsequent definitive trial of 
clinical and cost effectiveness. 
 
Methods 
The study was an assessor blinded, multicentre parallel group, individually 
randomised feasibility RCT comparing home based Reach-to-Grasp training with 
usual care upper limb therapy. Ethical approval was obtained from a South West 
Research Ethics Committee (REC) (ref number: 10/H0102/83). The trial was 
registered [ISRCTN56716589] and the trial protocol has been published 18. 
 
Participant selection and recruitment 
Inclusion criteria were: diagnosis of stroke less than 12 months prior to joining 
the study; discharged home (which could be a care home); informed consent; and 
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having a residual deficit in upper limb movement due to stroke. Residual arm deficit 
was defined as being unable to pick up a 6mm ball bearing from the table top, 
between index finger and thumb, and place it on a shelf 370 mm above the table 
which is a ‘pinch’ task from the Action Research Arm Test (ARAT) 19. Patients were 
excluded if they: had pre-stroke pathology preventing reach and grasp actions, were 
unable to lift their hand off their lap when asked to place their hand behind their head 
(a gross motor task from the ARAT), had severe fixed contractures of elbow or wrist 
(i.e. grade 4 on the Modified Ashworth Scale) 20. 
The target sample size was set at 60 participants recruited over 12 months. 
Participants were recruited from an area served by two large teaching hospitals and 
a smaller general hospital in the South West of England. Patients were identified and 
given an information sheet by therapists and research nurses in the three stroke 
services, and asked if they were willing to be contacted after discharge from hospital. 
Referrals were also sought from community rehabilitation services in the locality. 
Patients expressing interest were visited and invited to consent. Those consenting 
were asked to consider allowing family members to be invited to take part. 
Caregivers indicated willingness to be contacted by the research team by returning a 
tear-off slip in a stamped addressed envelope. They were asked to provide written 
informed consent. 
 
Randomisation and allocation concealment 
After completion of the baseline assessment, participants were randomly 
allocated in a one to one ratio to the Reach-to-Grasp or to the usual caregroup..  
Randomisation was via an independent web based service and the procedure used 
minimisation with a chance element of 85% in favour of the minimised allocation. 
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Minimisation was to balance time since stroke, severity of upper limb impairment; 
and distribution of group numbers within our small trial. Time since stroke was 
categorised as less than or equal to three calendar months post stroke, or more than 
three months post stroke. This three month cut off was chosen to balance the 
number of participants between groups who might be recovering at a faster rate. 
Baseline severity of upper limb impairment was categorised using scores on the 
ARAT in three subgroups defined in a previous trial 21. Group 1: score 0-3; Group 2 
score 4-28; Group 3 score 29-56.  The clinician providing Reach-to-Grasp treatment 
accessed the allocation by logging into a secure computer server,. The research 
therapist informed participants of their group allocationand intervention commenced 
within a week of randomisation to group. 
 
Data collection, assessor blinding and outcome measures  
Demographic and stroke details were collected at baseline only. All other 
measures were assessed at baseline (i.e. before randomisation), at seven weeks 
post-randomisation (i.e. immediately following the six week intervention period) and 
at 12 and 24 weeks after randomisation.  In a future RCT outcome at 24 weeks or 
longer would be the primary time point to assess longer term clinical effectiveness. 
The assessments were performed in the participant’s home by a researcher 
who was trained in the assessment procedures and blinded to group allocation. The 
research physiotherapist made the appointments for the assessment by telephone, 
and reminded participants not to reveal details of any treatment they had received to 
the assessor. Incidents of unblinding were recorded immediately after the 
assessment in the case report form. The assessors were asked to fill in a 
questionnaire at the end of their involvement in the study to identify whether they 
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knew or had guessed each participant’s group. These data were compared with the 
actual group allocation to determine the success of the blinding 22. 
Arm function was assessed using the ARAT 19; 23, 24, and the Wolf Motor 
Function Test (WMFT) 25,26. The ARAT consists of 19 items which are divided into 
four domains (grasp, grip, pinch and gross movement). The maximum score for the 
whole assessment is 57.  Each domain is Guttman scaled so that it is not necessary 
for patients to attempt every test item 23. The WMFT measures time to complete 
each of 15 tasks, eight of which require hand function. A maximum of 120 seconds is 
allowed for each task and quality of movement for each task is rated by the assessor 
on a 6-point ordinal scale (0-5) 25. Other outcomes measured were: the Motor 
Activity Log, a patient reported rating of quality of movement and amount of use 27 
and the Stroke Impact Scale, version 3.0 28.  
Caregiver interviews comprised assessing carer burden using the Carer 
Strain Index 29. data on Use of health and social care resources were collected by 
means of a bespoke questionnaire administered by telephone at 12 and 24 weeks 
post randomisation.  
To help inform the choice of primary outcome measure for a future trial, 
participants were asked at their final assessment whether they preferred the ARAT 
or WMFT.  
 
Interventions  
[Table 1 web] 
The Reach-to-Grasp intervention and the rationale for it has been described in detail 
elsewhere 14, using the Template for Intervention Description and Replication 30. A 
summary of the content of the intervention is given in Table 1. The Intervention 
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enabled even those with no active hand function to undertake goal-orientated 
activities with their affected arm. The therapist kept a log of which activities from the 
treatment manual were performed, and the number of repetitions of actions 
completed at each visit. Participants were asked to record on a log sheet the time 
they spent and number of repetitions achieved in their independent practice. The 
Reach-to-Grasp training replaced any usual care provided for improving arm 
function. All other usual care therapy services available to them, e.g. to improve 
balance, mobility, speech and language, cognition and activities of daily living, were 
continued. 
The control group received a package of usual care, delivered by National 
Health Service (NHS) occupational therapists and physiotherapists, which could 
include routine upper limb therapy. The NHS therapists were asked to record the 
length of time spent on the arm and the content of their therapy sessions on log 
sheets. They were also asked to record the number of repetitions of any functional 
arm movements practised. The log sheets were adapted from a checklist of 
physiotherapy treatments developed by Donaldson et al. 31.  
Participants of both groups were provided with a booklet about recovery after 
stroke.  The Reach-to-Grasp group additionally received information about the 
Reach-to-Grasp training.  
 
Adverse event data collection 
Participants were asked at each assessment visit if they had experienced pain 
in the shoulder, upper arm or hand, oedema in the hand, or had any falls since the 
last assessment.  An additional potential study-related adverse event was injury 
caused by equipment taken into the home for outcome assessment. Such 
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occurrences were monitored by the assessor at each visit. NHS therapists, research 
therapists and assessors were asked to report any serious adverse events to the trial 
manager as soon as they were made aware of them. 
 
Analysis 
This feasibility trial was not powered to detect a clinically important difference 
between the groups. Therefore, no formal statistical comparisons were made 16. 
Continuous measures were summarised using mean and standard deviation or 
median and interquartile range if the distribution was skewed.  Category measures 
were summarised as number and percentage. Unit costs were applied to resource 
required for trial treatment and resource use,. 
 
Results 
Results are presented in an order that responds to the list of the study objectives 
Recruitment and retention of participants 
Recruitment of 48 participants took place from December 2011 to April 2013 
(average rate 2.8/month). There were 2156 stroke admissions during this period, 102 
(4.7%) of whom were identified as potential study participants. Of these 102 potential 
participants, 60 were provided with information about the study (2.8% of admissions) 
and 52 assented to referral to the research team.  The main reasons for not 
providing study information were physical ability/disability (33/42) or because the 
patient was not discharged home (9/42) (see Figure 1 for full details).  
[Figure 1 near here] 
One participant withdrew before randomisation, 24 were allocated to the 
Reach-to-Grasp intervention group and 23 to the usual care group. The duration of 
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funding for the project allowed us to follow-up all participants to 12 weeks post 
randomisation, but only 32/47 (68%), to 24 weeks (see Figure 1).  
Participant characteristics 
[Table2 ] 
Table 2 shows participants’ characteristics. The sample had predominantly 
severe or moderately impaired arm function; 85% scoring less than 29/57 on the 
ARAT; 38% had no active hand function (scoring 3 or less on ARAT). Median time 
post-stroke on entry to the study was 124 days (approximately four months) (IQR: 
88, 227 days). With flexibility to join the study at any time up to 12 months post 
stroke, most participants opted to take part once any involvement with Early 
Supported Discharge teams or early support from other rehabilitation services had 
finished; 73% of participants entered the trial when they were over three months 
post-stroke, i.e. after the period of most rapid recovery. 
As anticipated with the randomisation by minimisation process similar 
numbers were allocated to each group, and the time post-stroke (≤3months versus 
>3months) and arm function severity (ARAT strata) were balanced across the groups 
(see Table 3). However, the median ARAT score at baseline was higher in the 
Reach-to-Grasp group (8.5 versus 4, Table ) and median time post-stroke was 
shorter (111.5 days in the Reach-to-Grasp group versus 135 days in the usual care 
group, Table 3). Other baseline characteristics were similar. 
 
Completeness of data collection 
At assessment visits the ARAT was completed for all available participants at 
each time point.  A breakdown of data missing from outcome measures is given in  
Figure 1 (and table 3(on the website) ). Adverse events information was collected at 
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130/162 (80%) visits. The health and social care questionnaire, completed 
predominantly by telephone, had a high response rate of 92% (43/47) at 12 weeks. 
The 32 participants assessed at 24 weeks all completed the questionnaire at the 
final follow up phone call. Data collection from caregivers was sparse. Overall, 37/47 
(79%) participants lived with others and yet only 26 (55%) participants gave consent 
for their family member to be approached, and only 12 carers consented to 
participate. Nine carers completed the Carer Strain Index at 12 weeks and six at 24 
weeks. 
 
 
Dose and content of upper limb treatment delivered to Reach-to-Grasp and 
usual care groups 
Twenty-three of the 24 participants allocated to the Reach-to-Grasp group 
completed the intervention, with 94% of the intended treatment visits completed 
(median 13.5/14 visits). Visits lasted a median 60.7 minutes (IQR: 59.8, 62.1), of 
which, 38.5 minutes (median; IQR: 35.4, 48.8) were engaged in active Reach-to-
Grasp training The median total number of repetitions per therapist-delivered session 
was 157 (IQR: 96, 211). The amount of self-practice outside of the therapist’s visits 
was poorly documented with no records available for three participants and only 
partial records for the remaining 21; (i.e. logs not completed on all 42 days). Median 
amount of practice recorded was 30 minutes (IQR: 22, 45) per day (see 
supplementary file Table i. for more details). 
NHS therapists’ records showed that 18 of the 23 participants in the usual 
care group (78%) received visits and upper limb treatment from community service 
therapists over the course of the six week intervention period. Those visited received 
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a median 10.5 (IQR: 6.0, 17.0) visits, with upper limb treatment lasting median 38.6 
minutes (IQR: 15.5, 44.2) per visit. Predominant aims of treatment (top 5 of 12 aims) 
for the upper limb in usual care were to improve: i) muscle activity in the paretic 
upper limb (21.0%); ii) range of motion (16.6%); iii) manipulative ability (10.7%); iv) 
alignment (10.1%); and v) incorporation of arm into balance and mobility activity 
(9.3%). A wide variety of treatment methods were recorded with passive, active 
assisted and active movements being most frequently used. Functional task practice 
was reported on 110 occasions. However the number of repetitions of functional 
tasks recorded per session was low: median 16.3 repetitions (IQR: 6.3, 24.3). 
 
Upper limb performance outcomes between groups  
[Figure 2 and tables 4&5 near here] 
Any interpretation of outcome results must be treated with caution since the 
groups were small and this feasibility study was not powered to test the efficacy of 
the intervention.  
The median ARAT scores post-intervention were unchanged in the usual care 
group, i.e. at 24 weeks the median scores were 4.  The median scores in the Reach-
to-Grasp group increased from a median of 8.5 at baseline to 14.5 at 24 weeks (see 
Figure 2A and Table 4); a difference of 6 points from baseline.   
At baseline, 20 participants in the Reach-to-Grasp group and 19 in usual care 
group were unable to do the eight tasks in the WMFT requiring hand function. Given 
the large proportion of tasks truncated at 120 seconds, (see supplementary file, 
results Table ii), we also summarised the number of tasks completed within 120 
seconds. This method for representing performance has been used previously; 
though it has not been tested for reliability 32. The number of tasks completed within 
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120 seconds increased in the Reach-to-Grasp group from  median (IQR) 6 (3.0, 
11.5) at baseline to 8.5 (4.5, 13.5) at 24 weeks (n=16 at 24 weeks) and in the usual 
care group median (IQR) from 4 (3.0, 10.0) at baseline to 6 (3.0, 14.0) at 24 weeks, 
(n=16 at 24 weeks) (see Figure 2B and Table5).  
Pertinent to the selection of primary outcome measure is the sensitivity to 
change in participants with differing severity of upper limb impairment. Figure 3A and 
3B show changes over time in subgroups of participants based on their ARAT score 
at baseline: Subgroup 1: score 0-3; subgroup 2 score 4-28; subgroup 3 score 29-56. 
The figures illustrate how the WMFT task completions was better for measuring 
change in the most severely impaired subgroup; while the ARAT was better for 
measuring change in those with in the higher scoring subgroup at baseline.  
Participants completing the 24 week assessment were consulted about their 
preference for the primary outcome (i.e. ARAT vs WMFT). 23/32 (72%) gave a 
preference. Of these, the 18 participants with some active hand function (scoring > 3 
on ARAT) were evenly split with nine preferring ARAT and nine preferring WMFT. 
The remaining five participants who scored 3 on ARAT preferred the WMFT because 
they could do more of the test items on the WMFT. 
 
Secondary outcomes 
Motor Activity Log: A rating of 3 or more is needed to report that the affected 
limb is effective for completing the task 33. The number of scores ≥3 increased 
marginally for both groups over the assessment times (see Table 6).  
[Table 6 near here] 
Stroke Impact Scale: Scores generally increased over time in all eight 
domains in both groups (see supplementary file results table iii). The median 
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perceived amount of overall recovery on the visual analogue scale was 50% in the 
usual care group at all the measurement time points, whereas the in the Reach-to-
Grasp group the median increased from 40% at baseline to 55% at 24 weeks.  
 
Blinding of assessor 
Assessor blinding was maintained in 33/45 (73%) of assessments at 7 weeks; 35/44 
(79.5%) at 12 weeks and 21/32 (65%) at 24 weeks. The increase in blinding success 
between weeks 7 and 12 may be explained either by variation in the memory of the 
assessor or by a change in personnel. Thirty nine instances of unblinding were 
described in the case report forms, resulting from participants’ conversations with the 
outcome assessor or viewing evidence of the Reach-to-Grasp intervention in the 
home. However in 20% of events the assessor drew the wrong conclusion regarding 
group allocation.  
 
Frequency of adverse events  
Total incidence of upper limb adverse events (i.e. all instances of shoulder pain, 
hand pain or hand oedema) was similar between groups (baseline assessment: 
Reach-to-Grasp 22; usual care 19; all post intervention assessments Reach-to-
Grasp 27; usual care 25). These results include repeat reports from the same 18 
(38%) participants.  Nine falls were reported at post intervention assessments 
(Reach-to-Grasp 3; usual care 6). There were no injuries caused by equipment 
brought into the home for the study. A total of 12 serious adverse events (death, 
hospitalisation) were reported, six in the Reach-to-Grasp group and six in the usual 
care group; all deemed ‘unlikely to be’ or ‘not related’ to the intervention.  
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Health and Social Care resource use  
There was a high completion rate for the questionnaire at 12 and 24 weeks 
respectively (43/44; 32/32), suggesting its content and format were appropriate for 
this study population. However, some amendments will be made for a future RCT, 
such as increasing the number of resource use items listed to reflect a more diverse 
range of rehabilitation services that were used by participants.  Mean cost of the 
Reach-to-Grasp intervention was calculated to be £677 per participant. 
 
Discussion 
This feasibility study has provided realistic estimates of recruitment, retention 
and data completeness. It has established the characteristics of the participants 
recruited to the study, the dose and content of usual care upper limb therapy and 
Reach-to-Grasp training received, and the safety of the intervention. The study has 
also provided data to inform the primary outcome measure and sample size for the 
future RCT. It adds to the findings of our previous publication, which described the 
intervention and indicated that participants found the intervention acceptable, 
sufficiently challenging and enabled them to achieve activities that were meaningful 
to them. 14 
 
The size of the population from which the sample is recruited in stroke 
rehabilitation trials is rarely reported therefore gauging the success of recruitment is 
difficult.  Recruitment as a percentage of stroke population, at 2.8% is very low. The 
reasons why patients admitted were not considered as potential participants by staff 
identifying patients was not recorded. These would include deaths, people missed 
from the screening procedures, not fitting eligibility criteria and people who may not 
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have been discharged in time to participate in the study.  However it is also likely that 
therapists may have chosen not to approach some patients for other reasons that 
have been reported for another UK stroke rehabilitation trial 35. The proportion of 
admissions identified is similar is to another recent UK home based upper limb 
stroke trial 36. Our average recruitment rate of 2.8 participants per month, although 
less than our target, is comparable to the best recruitment rate (2.5 per month) seen 
in a previous hospital-based stroke rehabilitation trial recruiting from inpatient stroke 
rehabilitation services in 12 hospitals in the UK 37.   
Recruitment of caregivers was low, partly because only about two thirds of 
participants living with family gave permission for their relative to be approached. 
With caregivers not always being present in the home when the researcher visited 
the participant, recruitment was often reliant on caregivers expressing willingness to 
be recruited by post. Effective strategies to boost engagement of family members will 
be needed if caregiver burden is to be measured in future trials. These strategies 
could include having clearer explanation about expectations of caregivers. 
There was low attrition (7%) up to 12 weeks post-randomisation and although 
we were unable to fully determine retention at 24 weeks, 89% of those who reached 
24 weeks before the end of the study were assessed. This fact suggests that attrition 
is unlikely to be a serious problem to the successful completion of a future large trial. 
Other stroke rehabilitation trials have reported retention of 80% at 6 months 38 and 
69% at 9 months 39.  
Completion of outcome measures was high at each time point, but there were 
notably more missing data within the WMFT and the Motor Activity Log, suggesting 
that these were less easy to complete. Carrying out both ARAT and WMFT along 
with the secondary measures was a lengthy process; taking up to two hours. Rigour 
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in recording adverse events, at 80%, was lower than for completion of the outcome 
measures and complicated by repeat reporting of pain from the same individuals. An 
efficient method identifying repeat events will be needed for future studies. 
 
Blinding is an acknowledged problem in rehabilitation trials 22. The use of 
performance rated outcome measures necessitates face to face contact of the 
assessor and participants and it seems that, despite reminders not to reveal details 
of any treatment, participants sometimes revealed their group allocation. Thisis a 
potential source of bias in a future study and reminders could be strengthened in 
future studies.. 
The high number of repetitions achieved in Reach-to-Grasp training within the 
therapist’s visits demonstrates that intensive practice is achievable with moderate to 
severely impaired stroke patients in a domiciliary setting; without additional upper 
limb pain, oedema or falls. A larger trial in the UK will require that NHS therapists 
deliver the interventions. The trial will need to determine whether service therapists 
trained in the intervention can achieve such high repetition rates as in this feasibility 
study.  
The difficulty in obtaining data from participants about their Reach-to-Grasp 
practice between therapist’s visits reinforces the need for better methods for 
recording self-practice 40. Providing tally counters to participants or more automated 
methods may improve reporting, but this requires further study.    
The usual care therapy data collected from community rehabilitation services 
indicated that 80% of participants were still seeing a community therapist, but that 
their intervention was less frequent than the Reach-to-Grasp training. Although more 
variable, on average, the usual care therapy sessions were of similar duration to the 
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training time in the Reach-to-Grasp therapy visits. However the content was 
different; with more impairment oriented treatment and less intensity of task practice. 
Repetitions of functional tasks carried out in usual care therapy amounted to around 
10% of that achieved in the Reach-to-Grasp group, which is probably insufficient to 
enable the neuroplastic changes necessary for motor learning to occur in the neural 
networks that mediate task specific motor functions 41-43. 
Most participants in this study preferred the WMFT, notably those with the 
most severe upper limb impairment, because they could complete more items. 
However there are other factors that are important in choosing the primary outcome 
for a large trial. Both observer-rated assessments of upper limb performance (ARAT 
and WMFT) have strengths and limitations. They can be lengthy to complete and 
require cumbersome kits to be taken into the home; both factors being greater for 
WMFT than ARAT. Our results indicated differing suitability for measuring change 
according to severity of upper limb impairment. The ease of test administration and 
scoring, facilitated by the Guttman scaling, favoured the ARAT over WMFT, resulting 
in a smaller number of missing data in the ARAT compared to the WMFT; an 
important consideration for a definitive RCT.  Given these pragmatic reasons we 
have decided the ARAT will be our preferred primary outcome measure for the RCT. 
With a minimally clinical important difference of 5.7 [34 van der Lee]. and based on 
the data from this feasibility trial with a pooled standard deviation for the ARAT 
scores of 18, and with a correlation between baseline and follow-up scores of 0.72, it 
is estimated that, 240 participants (120 per group) will provide the study with 90% 
power at the 5% significance level and allowing for attrition of 15% given the 
likelihood of greater attrition in a larger multicentre trial.  
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 In our earlier article on this intervention, we reported that 85% of Reach-to-
Grasp participants felt their arm had improved 14 in activity domains including meal 
preparation and self-care, a considerable proportion of which requires bimanual 
coordination 14.  The ARAT, however, does not comprise any bimanual tasks.  
Patient reported outcomes should therefore be included in future trials to ensure that 
changes in bimanual activities are adequately captured. 
A definitive RCT should contain a full economic evaluation to estimate the 
cost-effectiveness of the intervention versus usual care. Telephone administration of 
the Health and Social Care resource use questionnaire is suggested as the 
completion rate was very good. A health-related quality of life measure such as the 
EQ-5D or the SF-6D should be used in a full trial in order to estimate quality-adjusted 
life years. 
In conclusion, the findings from this feasibility study indicate that a home-
based, intensive task-specific upper limb rehabilitation programme to improve reach 
to grasp function after stroke is safe and a larger trial is feasible.   
 
Clinical Messages  
• Undertaking a relatively high number of repetitions; 10 times as many as in usual 
care, without additional adverse effects is feasible. 
• Conducting a randomised controlled trial to compare home-based task-specific 
Reach-to-Grasp training with usual care practice after stroke is feasible and safe.  
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Figure Legends 
Figure 1. Flow of participants 
Notes:  
1 Some patients may be ineligible for more than one reason  
2 due to recent bereavement and discharge to nursing home 
3 Number of patients with any outcome data available 
4 study was stopped before 11 patients reached 6 month follow-up 
 
Figure 2. ARAT and WMFT scores over time points 
Figure 3. ARAT and WMFT scores at each time point by ARAT baseline score 
ARAT score at baseline: Subgroup 1: score 0-3; subgroup 2 score 4-28; subgroup 3 score 29-56 
The marked reduction in median score at 6 months in subgroup 3 is explained by an individual who 
developed severe shoulder pain.  
 
Supplementary results tables i-iii are accessible from the University of the 
West of England's research repository https://eprints.uwe.ac.uk/ 
 
 
